Tag: sotrovimab

Biden Administration Stops Shipments of COVID-19 Treatment to All States

The U.S. government on March 5 immediately halted all shipments of a COVID-19 treatment to states and ordered health care providers not to use the drug. The actions were taken because of the increasing prevalence of BA.2, a subvariant of Omicron, which is itself a variant of the CCP (Chinese Communist Party) virus, also known as SARS-CoV-2,…


Biden Admin Cuts Off 14 More States From COVID-19 Treatment as BA.2 Variant Spreads

President Joe Biden’s administration has ordered 14 additional states to stop using a COVID-19 treatment made by GlaxoSmithKline and Vir Biotechnology. The Department of Health and Human Services (HHS) said March 30 it has paused shipments of the drug, sotrovimab, to the states, bringing the total number of states that are no longer receiving doses to…


FDA Tells Doctors in 8 States to Stop Using COVID-19 Treatment

U.S. drug regulators have directed health care workers in eight states to stop using a COVID-19 treatment because it may not be effective against an Omicron subvariant that is rising in prevalence. The Food and Drug Administration (FDA) said sotrovimab, a monoclonal antibody used to treat COVID-19, can no longer be used in Connecticut, Maine,…


FDA Restricts Use of 2 Monoclonal Antibody Treatments

The U.S. Food and Drug Administration (FDA) announced Jan. 24 it is restricting the use of two monoclonal antibody treatments for COVID-19, saying data show such treatments are “highly unlikely” to be active against the Omicron variant, currently the dominant strain in the country. Monoclonal antibodies are laboratory-created proteins that mimic natural antibodies the body…


Texas Asks Biden Administration for Monoclonal Antibodies, Testing Kits

Texas Gov. Greg Abbott has asked the Biden administration to send a crucial COVID-19 treatment and testing kits to the state amid the Omicron virus variant surge. Abbott, a Republican, announced Friday that the state requested resources from the federal government, including monoclonal antibodies. “Detecting COVID-19 and preventing COVID-related hospitalizations are critical to our fight…


UK Regulator Approves 2nd COVID-19 Antibody Treatment

The UK’s medicines regulator on Thursday approved an antibody treatment for COVID-19, the disease caused by the CCP virus. Xevudy (sotrovimab), developed by GlaxoSmithKline (GSK) and Vir Biotechnology, is the second monoclonal antibody treatment approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) after it approved Lagevrio (molnupiravir) last month. The drug is administered by intravenous infusion…